In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer to market 38 generic cancer drugs for Strides Arcolab

Executive Summary

In its second agreement with Pfizer Inc. this year, Indian firm Strides Arcolab Ltd. has licensed the Big Pharma rights to commercialize 38 generic cancer drugs in the EU, Canada, Australia, New Zealand, Japan, and Korea. In addition, Pfizer gets US rights to niche sterile injectables.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies